Loading…

Arteris, Inc.AIPCompetitor analysis, valuation and peers

United States · USD·Information Technology›Semiconductors

Licenses network-on-chip semiconductor IP that connects processor cores and components inside complex chip designs.

Momentum weak 20
Mkt cap
$937M
US dollars, full cap
Free float
81%
of shares outstanding
$/day
$11.4M
20-day average traded
Fwd P/E
314.0×
forward earnings
ROIC−WACC
n/a
WACC 14.6%
Hurdle
n/a
no reverse DCF
Next earnings
105 days
3 Mar 2027
Close · USD$18.84
1D+1.4%
1W-7.3%
1M-4.7%
3M-21.4%
6M-46.1%
YTD+21.6%
1Y+40.9%
ATR %7.4%
Beta3.30
52w lowhigh62.5% off high

What Arteris does

Licenses network-on-chip semiconductor IP that connects processor cores and components inside complex chip designs.

Charges a licence fee when a chip designer adopts its interconnect IP, then collects royalties on each chip shipped, so revenue builds from design wins that take years to turn into volume production. Automotive and consumer chips are major users.

Products and services

  • Network-on-chip (NoC) IP
  • FlexNoC/Ncore interconnect products

Customers

  • Chip designers building complex SoCs (automotive,

Where it sits in the supply chain

  • Information technology
  • Semiconductor IP
  • Network-on-chip (NoC) interconnect IP

What could go right

  • Growing SoC complexity driving interconnect IP demand

What could go wrong

  • Customer design-win concentration
  • Semiconductor design-cycle timing risk

Moat: narrow (IP / patents, switching costs). Interconnect IP is deeply embedded in customer chip designs, making it costly to switch mid-design.

Headquarters: Campbell, California, US · Founded: 2004 · Employees: 299

Named competitors

Arteris at a glance

Size Arteris (AIP) is a United States Information Technology company (Semiconductors) with a market value of $937M, the 2271st largest of 3,085 United States companies the cockpit tracks. Shares closed at $18.84 on 18 Nov 2026.

Performance Over six months the shares fell 46.1%, against -28.8% for the median peer and -2.2% for the United States market (cap-weighted) — 5th lowest of 20 in its peer set.

Growth Revenue grew 41.0% over the last twelve months (peer median +4.2%); the operating margin is -43.1% (peer median 3.7%).

Valuation It trades at 314.0× forward earnings against a peer median of 26.8× (most expensive of 13).

Backlog Backlog (remaining performance obligations) was $131M at 30 Sep 2026, up 30% on a year earlier — 1.4 years of trailing revenue. Backlog detail →

Short interest Short interest is 4.8% of the free float (30 Oct 2026).

Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).

Relative performance

5010021 May 202621 Aug 202618 Nov 2026Peer median 71AIP 52
Six months, rebased to 100: Arteris against the median of its 20 peers (local-currency closes).

Arteris financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$93.0M$70.6M$57.7M$53.7M$50.4M
Revenue growth—+22%+8%+7%—
Gross profit$78.1M$61.2M$49.2M$46.3M$44.5M
EBITDA-$34.9M-$29.8M-$28.2M-$32.1M-$26.8M
Net income-$41.7M-$34.7M-$33.6M-$36.9M-$27.4M
Free cash flow$2.17M$5.34M-$1.04M-$17.2M-$7.82M
Capital expenditure$1.40M$1.39M$324,000$1.50M$1.05M
Total debt$9.17M$5.97M$5.99M$7.75M$3.62M

Quarterly statements and history in the cockpit →

Arteris competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-60%-40%-20%0%+20%-20%0%601908688790688662611668826168859100054180163714300889496668823068843930049300201749913008422458AIP6-month return →1-month return →
Up and to the right = strong over both horizons. Arteris is the large dot.

Fundamentals: revenue growth against valuation

-25%0%+25%+50%0×100×200×300×688662688261688591000541801649666884394991300708300842AIPRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Arteris is the large dot.

Arteris competitors and peer comparison

Head to head with its named competitors (AIP vs ARM vs SNPS vs CDNS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Arteris AIP$937M-46%+41%-43%314.0×n/a
Arm ARM$195B-29%+24%17%70.9×n/a
Synopsys SNPS$83.2B-13%+46%12%24.6×38.8%
Cadence Design Systems CDNS$83.9B-13%+18%30%32.5×29.5%
CEVA CEVA$719M-34%+8%-10%34.0×51.1%

How Arteris compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Arteris against its 20 peers (data as of 18 Nov 2026)
MeasureAIPPeer medianRank in peer set
1-month return-4.7%-16.6%4th highest of 21
6-month return-46.1%-28.8%5th lowest of 20
Distance from 52-week high-62.5%-50.2%6th lowest of 21
Revenue growth (TTM)+41.0%+4.2%2nd highest of 21
Operating margin-43.1%3.7%3rd lowest of 21
Forward P/E314.0×26.8×most expensive of 13

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Arteris AIPUnited States$937M-46%+41%-43%314.0×n/an/a
Beijing Jingyuntong Technology 601908.SSChina$938M-38%-32%-49%n/a-6.4%-5.1%
Beijing OnMicro Electronics 688790.SSChina$935M-59%-10%-16%n/a38.0%+26.8%
Guangdong Fuxin Technology 688662.SSChina$939M-17%+15%13%62.8×n/an/a
Hannstar Display 6116.TWTaiwan$934M+15%-1%-29%n/an/an/a
Suzhou Oriental Semiconductor 688261.SSChina$930M-39%+18%0%40.1×n/an/a
Telink Semiconductor (Shanghai) 688591.SSChina$948M-25%+7%4%74.0×n/an/a
Foshan Electrical and Lighting 000541.SZChina$951M-8%-3%-2%21.3×n/an/a
BASiC Semiconductor 9971.HKHong Kong$917Mn/a+4%-104%n/an/an/a
Sitronix Technology 8016.TWTaiwan$913M-9%+25%14%9.7×-8.7%+6.6%
Ennostar 3714.TWTaiwan$910M-23%+4%-10%n/an/an/a
Shenzhen EXC-LED Technology 300889.SZChina$968M-29%+20%-8%n/an/an/a
Parade Technologies 4966.TWOTaiwan$902M-50%-3%14%14.8×-0.1%+1.6%
Shanghai Prisemi Electronics 688230.SSChina$898M-29%+31%19%n/a28.8%+1.3%
Guizhou Zhenhua Fengguang Semiconductor 688439.SSChina$979M-35%-39%4%13.9×16.1%+16.1%
Shanghai Fortune Techgroup 300493.SZChina$895M-25%+3%3%51.6×32.8%+15.8%
Eastcompeace Technology 002017.SZChina$986M-38%+4%10%n/a28.2%+4.5%
GCS 4991.TWOTaiwan$993M-53%+52%20%26.9×35.4%+8.2%
Focus Lightings Tech 300708.SZChina$996M-25%-38%9%26.6×n/an/a
Wuxi DK Electronic Materials 300842.SZChina$879M-55%+36%4%47.8×n/an/a
ELAN Microelectronics 2458.TWTaiwan$999M-17%-8%21%17.5×-3.7%-4.0%

Arteris backlog

Arteris reported $131M of remaining performance obligations at 30 Sep 2026, up 30% from a year earlier and down 0% from the previous quarter. That is 1.4 years of trailing revenue already under contract. Book-to-bill last quarter: 1.00.

Questions

Who are Arteris's main competitors?
Named competitors: Arm Holdings (ARM), Synopsys (SNPS), Cadence Design Systems (CDNS), CEVA (CEVA). The cockpit's measured peer set (industry) also includes Beijing Jingyuntong Technology (601908.SS), Beijing OnMicro Electronics (688790.SS), Guangdong Fuxin Technology (688662.SS), Hannstar Display (6116.TW), Suzhou Oriental Semiconductor (688261.SS), Telink Semiconductor (Shanghai) (688591.SS).
Is Arteris expensive compared with its peers?
On forward p/e it trades at 314.0× against a peer median of 26.8×, most expensive of 13 in its peer set.
How has Arteris stock performed?
Over six months to 18 Nov 2026 the shares returned -46.1% against -28.8% for the median peer; over one year +40.9%.
What is Arteris's backlog?
Arteris's remaining performance obligations (contracted revenue not yet recognised) were $131M at 30 Sep 2026, +30% on a year earlier.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.